申请人:Besterman M. Jeffrey
公开号:US20070293675A1
公开(公告)日:2007-12-20
The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not require a β-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.
本发明涉及细菌抗生素耐药性,特别是涉及克服细菌抗生素耐药性的组合物和方法。本发明提供了新型β-内酰胺酶抑制剂,其与目前已有的天然产物和半合成β-内酰胺酶抑制剂在结构上无关,且不需要β-内酰胺药效团。本发明还提供了用于抑制细菌生长的药物组合物和方法。